
Faricimab approved for treatment of nAMD, DMO by European Commission
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOcjJOVWdHNUNyckwxNnBLbV9oNUs3Nm5TYnJDajA2VHJXQ1NBMjE2d21MLWhfd2sxc1BpTkJyYTRrc1lVR1BWOUp1VjhxdGNmLTd3eGRZMGQ4VXBpaV9nbGF0WVlkNWtjQnpzektLcDNYUUVzeXZSZnNVZ0tpS1BOOWMtSHczYk1GeHFaRkhvdGloaWZkLVhBN0NIR3FWY2R2Y2w4NnNkSUFvcTg?oc=5" target="_blank">Faricimab approved for treatment of nAMD, DMO by European Commission</a>&nbsp;&nbsp;<font color="#6f6f6f">Ophthalmology Times</font>

